Eko Foundation Analysis Software with Transformers (EFAST) vs ZEUS System (Zio Watch)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

EFAST by Eko Health is designed for real-time, point-of-care detection of structural murmurs and atrial fibrillation during routine auscultation using a digital stethoscope. In contrast, the ZEUS System (Zio Watch) by iRhythm Technologies provides long-term continuous cardiac monitoring via a wearable device to detect and characterize atrial fibrillation and other arrhythmias over an extended period. Therefore, EFAST is suited for immediate diagnostic assistance during exams, while ZEUS is for prolonged arrhythmia surveillance.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if you require real-time, AI-powered cardiac insights directly during a routine physical examination. This tool is ideal for clinicians needing immediate detection of structural murmurs associated with heart disease and atrial fibrillation at the point of care, leveraging enhanced auscultation with digital stethoscopes to streamline initial diagnostic screening.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose ZEUS System (Zio Watch) if…

Choose the ZEUS System (Zio Watch) if your primary need is long-term, continuous cardiac monitoring to detect and characterize intermittent or asymptomatic arrhythmias over an extended period. This wearable solution is best suited for patients requiring up to 14 days of observation to capture elusive AFib episodes or other cardiac arrhythmias that might be missed in a single office visit, providing a comprehensive overview of arrhythmia burden.

View ZEUS System (Zio Watch) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Foundation Analysis Software with Transformers (EFAST) ZEUS System (Zio Watch)
Pricing Subscription-based, contact for details Contact vendor
Deployment Cloud-based Software as a Medical Device (SaMD) Cloud-based system with a wearable device
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST integrates seamlessly into existing clinical workflows by enhancing the traditional auscultation process with real-time AI analysis and enhanced audio. This allows clinicians to gain immediate insights during a routine exam. While ZEUS offers a patient-friendly wearable and provider portal, EFAST's real-time, in-workflow feedback provides a more direct and immediate usability advantage for the clinician during an encounter.

Clinical Value

ZEUS System (Zio Watch)

While EFAST provides valuable real-time detection of structural murmurs and AFib during an exam, the ZEUS System offers long-term continuous cardiac monitoring for up to 14 days. This extended monitoring capability is crucial for detecting and characterizing intermittent arrhythmias, including AFib burden, which might be missed in a single point-in-time assessment. The high physician agreement (99%) for ZEUS reports further underscores its robust clinical utility for comprehensive arrhythmia diagnosis and management.

Pricing & Value

Eko Foundation Analysis Software with Transformers (EFAST)

Tool A, EFAST, provides more transparency regarding its pricing structure, indicating it is subscription-based with a yearly Eko+ membership and an approximate daily cost for its stethoscope technology. In contrast, Tool B, the ZEUS System, only states 'contact vendor' with no specific pricing details provided in the facts. This greater transparency gives Tool A an edge in this dimension.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being cloud-based, HIPAA compliant, and having Business Associate Agreements (BAAs). EFAST explicitly mentions EMR integration for streamlined documentation, and web search confirms that iRhythm's ZioSuite platform, which includes the ZEUS System, also offers seamless integration with various EMR systems. Both are well-equipped for deployment within healthcare organizations.

Innovation

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST brings significant innovation by integrating advanced AI for real-time structural murmur and AFib detection directly into a traditional stethoscope during a routine physical exam. This transforms a long-standing clinical practice with immediate, AI-powered insights. While the ZEUS System's long-term wearable monitoring is also innovative, EFAST's application of AI to enhance a fundamental, real-time diagnostic interaction represents a more novel disruption of an established workflow.

Support & Docs

Tie

Neither tool's provided facts included specific details about support or documentation. Web searches indicate that both Eko Health and iRhythm Technologies offer standard support resources, including support centers, FAQs, user manuals, and clinical resources for healthcare professionals and patients. Without more granular information on the quality or breadth of these offerings, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Foundation Analysis Software with Transformers (EFAST) ZEUS System (Zio Watch)
Tool Name Eko Foundation Analysis Software with Transformers (EFAST) ZEUS System (Zio Watch)
Company Eko Health iRhythm Technologies
Primary Function Advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. FDA-cleared, AI-powered wearable for long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias, providing actionable insights for physicians.
Key AI Detection Capabilities AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity) AI-powered algorithm (ZEUS System) for advanced arrhythmia detection and analysis; Detects and characterizes Atrial Fibrillation (AFib) burden
Monitoring Duration/Type Real-time AI analysis during auscultation Long-term continuous monitoring for up to 14 days

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and ZEUS System (Zio Watch).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Foundation Analysis Software with Transformers (EFAST) provides real-time AI analysis during auscultation using a digital stethoscope for routine exams. In contrast, the ZEUS System (Zio Watch) utilizes a wearable biosensor for long-term continuous ECG and PPG data collection over several days.
EFAST is designed to assist clinicians in identifying structural murmurs associated with heart disease, in addition to detecting atrial fibrillation. The ZEUS System (Zio Watch) is specifically designed to detect and characterize Atrial Fibrillation (AFib) burden and other cardiac arrhythmias.
EFAST provides real-time AI analysis during routine auscultation exams, offering immediate insights at the point of care. The ZEUS System (Zio Watch) offers long-term continuous monitoring for up to 14 days.
EFAST provides real-time AI analysis, waveform visualization, and guided exams directly through Eko digital stethoscopes, with EMR integration for documentation. The ZEUS System (Zio Watch) delivers clinically actionable reports via the ZioSuite portal and a provider mobile app for interpretation and patient management.
EFAST boasts an AFib detection sensitivity of 95% and specificity of 94%. The ZEUS System (Zio Watch) provides advanced arrhythmia detection and analysis with clinically actionable reports, demonstrating high physician agreement at 99%.
EFAST seamlessly integrates with Eko digital stethoscopes, such as the CORE 500, for its real-time analysis. The ZEUS System (Zio Watch) requires its wearable biosensor, the Zio Watch, for continuous ECG and PPG data collection.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.